KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
67 hedge funds and large institutions have $148M invested in Kindred Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $82K
Holders
67
Holding in Top 10
–
Calls
$1K
Puts
$82K
Top Buyers
| 1 | +$5M | |
| 2 | +$4.5M | |
| 3 | +$2.84M | |
| 4 |
PGC
Pacific Grove Capital
San Francisco,
California
|
+$1.41M |
| 5 |
BlackRock
New York
|
+$963K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$616K | |
| 3 | -$361K | |
| 4 |
Millennium Management
New York
|
-$289K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$170K |